MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3171/2024.10.jns241643

Медицинская библиотека · Journal of neurosurgery · 2025

Auricular vagus nerve stimulation for mitigation of inflammation and vasospasm in subarachnoid hemorrhage: a single-institution randomized controlled trial.

Huguenard Anna L, Tan Gansheng, Rivet Dennis J, Gao Feng, Johnson Gabrielle W, Adamek Markus, Coxon Andrew T, Kummer Terrance T, Osbun Joshua W, Vellimana Ananth K, Limbrick David D, Zipfel Gregory J, Brunner Peter, Leuthardt Eric C

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

Inflammation contributes to morbidity following subarachnoid hemorrhage (SAH). The authors of this study evaluate how applying noninvasive transauricular vagus nerve stimulation (taVNS) can target this deleterious inflammatory response following SAH and reduce the rate of radiographic vasospasm.

METHODS

In this prospective, triple-blinded, randomized controlled trial, 27 patients were randomized to taVNS or sham stimulation. Serial blood and CSF samples were collected every 3 days to quantify inflammatory markers. Radiographic cerebral vasospasm severity and functional outcomes (modified Rankin Scale scores) were analyzed.

RESULTS

No adverse events occurred. Radiographic vasospasm was significantly reduced (p = 0.018), with serial vessel caliber measurements demonstrating a more rapid return to normal than in the sham-treated group (p < 0.001). In the taVNS group, tumor necrosis factor-α was significantly reduced in both plasma (days 7 and 10) and CSF (day 13); interleukin-6 was also significantly reduced in plasma (day 4) and CSF (day 13) (p < 0.05). Patients receiving taVNS had higher rates of favorable outcomes at discharge (38.4% vs 21.4%) and first follow-up (76.9% vs 57.1%). Patients treated with taVNS had significant improvement in modified Rankin Scale scores from admission to first follow-up (p = 0.014), unlike patients in the sham-treated group (p = 0.18). The taVNS group had a significantly lower rate of discharge to a skilled nursing facility or hospice (p = 0.04).

CONCLUSIONS

taVNS is a noninvasive method of neuro- and systemic immunomodulation. This trial supports the finding that taVNS following SAH can mitigate the inflammatory response, reduce radiographic vasospasm, and potentially improve functional and neurological outcomes.

Для цитирования: Huguenard Anna L, Tan Gansheng, Rivet Dennis J, Gao Feng, Johnson Gabrielle W, Adamek Markus, Coxon Andrew T, Kummer Terrance T, Osbun Joshua W, Vellimana Ananth K, Limbrick David D, Zipfel Gregory J, Brunner Peter, Leuthardt Eric C. Auricular vagus nerve stimulation for mitigation of inflammation and vasospasm in subarachnoid hemorrhage: a single-institution randomized controlled trial.. Journal of neurosurgery. 2025. DOI: 10.3171/2024.10.jns241643.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.